Your Article Summary
See Latest ArticlesContinuous Glucose Monitoring Health Outcomes
Diabetes Technology & Therapeutics, 06/04/09
Edelman SV et al. - Continuous glucose monitoring (CGM) is a new tool that has recently become available to people with diabetes. Recent data using real-time CGM suggest significant improvements in important clinical outcomes such as hemoglobin A1c, time spent in the hypo- and hyperglycemic range, glucose variability, quality of life, and perceived value to physicians and patients. Additional variables such as age of the subject and duration of sensor use have important implications in defining the benefits of CGM in a heterogeneous population with diabetes.
Related Articles
Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment: Evidence from the JDRF-CGM Trial
Diabetes Care, 10/30/09
Relevance Score: 87%
Improved Quality of Glycemic Control and Reduced Glycemic Variability with Use of Continuous Glucose Monitoring
Diabetes Technology & Therapeutics, 11/17/09
Relevance Score: 84%
Continuous Glucose Monitor Shows Potential for Early Hypoglycemia Detection in Hospitalized Patients
Diabetes Technology & Therapeutics, 11/18/09
Relevance Score: 80%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment with alpha-lipoic acid reduces asymmetric dimethylarginine in patients with type 2 diabetes mellitus
Translational Research, The Journal of Laboratory and Clinical Medicine, 12/11/09
Are short women at risk for gestational diabetes mellitus
European Journal of Endocrinology, 12/11/09
Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease
Expert Opinion in Pharmacotherapy, 12/11/09
Today in Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Does Normal Thyroid Gland by Ultrasonography match with Normal Serum Thyroid Hormones and Negative Thyroid Antibodies
Experimental and Clinical Endocrinology & Diabetes, 12/10/09
False Positive test Results for Pheochromocytoma from 2000 to 2008
Experimental and Clinical Endocrinology & Diabetes, 12/10/09
No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
European Journal of Nuclear Medicine & Molecular Imaging, 12/08/09